Biotech

All Articles

Navigator increases $100M to develop new autoimmune pipe

.Navigator Medicines has outfitted itself along with $one hundred million in series A funds as the y...

Duality looks for cash for ADC trials as IPO wave spreads to Asia

.China's Duality Biotherapeutics has actually filed (PDF) documents for a Hong Kong IPO, looking for...

YolTech sells China civil liberties to gene editing therapy for $29M

.4 months after Mandarin genetics editing and enhancing company YolTech Therapeutics took its own ch...

Addex stock rises after Indivior offers up to $300M for substance

.Indivior is actually getting a small molecule allosteric modulator made to handle compound usage ai...

Molecular Partners changes AML trial over 'suboptimal direct exposure'

.Molecular Partners has identified "suboptimal direct exposure" to its tetra-specific T-cell engager...

Despite blended market, an equity capital revival may be coming in Europe: PitchBook

.While the biotech assets scene in Europe has actually reduced somewhat following a COVID-19 financi...

8 months after a $213M fundraise, gene editor Volume creates reduces

.After raising $213 thousand in 2023-- among the year's biggest personal biotech shots-- Tome Biosci...

BioMarin creates director staff with biotech veterinarians-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Biopharma Q2 VC reached highest level because '22, while M&ampA slowed

.Venture capital backing right into biopharma rose to $9.2 billion across 215 sell the 2nd one-fourt...

Bicara, Zenas seek IPOs to drive late-phase properties toward market

.Bicara Therapies and Zenas Biopharma have delivered clean incentive to the IPO market along with fi...